CheckMyRecalls

10,013 recalls · updated 20 Nov 2026

Unichem Pharmaceuticals USA Inc. recalls Cyclobenzaprine Hydrochloride…

Unichem Pharmaceuticals USA Inc. recalls Cyclobenzaprine Hydrochloride Tablets

Read the official FDA notice

Published
24 Sept 2025
Units affected
230 90-count bottles
Agency
FDA
Country
United States

The hazard

Labeling: Label Mix Up; Bottles of Meloxicam USP, 7.5mg, 90-count tablets (yellow in color), were labeled as Cyclobenzaprine Hydrochloride Tablets USP, 10 mg 90-count tablets (blue in color).

Classification: Class I — the most serious type: there is a reasonable chance this product could cause serious health problems or death.

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

Cyclobenzaprine Hydrochloride Tablets, USP, 10 mg, 90-count bottle, RX only, Manufactured by: Unichem Laboratories, Ltd, Pilerne Ind. Estate, Pilerne, Bardez, Goa, India; Manufactured for: Unichem Pharmaceuticals (USA), Inc. East Brunswick, NJ. NDC 29300-415-19.

Brand / company
Unichem Pharmaceuticals USA Inc.
Codes / lots
Lot No: GMML24026A, Expires: 09/30/2027
Distribution
Nationwide within the U.S.A
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 24 Sept 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.